Pharma Past Propels Julie Brown To GSK’s CFO Position
How Will New CFO Spend $7bn Haleon Dividend?
GSK has poached its new chief financial officer from fashion brand Burberry, but Julie Brown’s experience at AstraZeneca and Roche will give her insights into how to lead GSK into its next phase.
You may also be interested in...
A second activist investor has called for GSK to consider replacing Emma Walmsley as CEO
, and has underlined competitive threats to a key pipeline candidate.
The gene therapy company could have two products approved by the end of 2024 – with ambitions for long-term expansion beyond rare disease.
The results could help BI and Zealand Pharma challenge in the MASH field, though analysts are wary of claims around fibrosis improvement.